Financial Instruments - Investments in Debt and Marketable Equity Securities Disclosure (Details) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Cost or Amortized Cost
Cash and cash equivalents, at carrying value	$ 183,538	$ 124,743	$ 107,129	$ 149,759
Restricted cash	128	229	1,274	1,241
Cash, cash equivalents, and restricted cash:
Total cash, cash equivalents, and restricted cash	183,666	124,972	$ 108,403	$ 151,000
Fair Value, Measurements, Recurring
Cost or Amortized Cost
Restricted cash	128	229
Cash, cash equivalents, and available-for-sale debt securities, amortized cost	183,666	124,972
Unrealized Gains (Losses)
Unrealized Gains	0	0
Unrealized Losses	0	0
Estimated Fair Value
Cash equivalents	137,293	65,599
Cash, cash equivalents, and available-for-sale debt securities	183,666	124,972
Cash, cash equivalents, and restricted cash:
Total cash, cash equivalents, and restricted cash	183,666	124,972
Cash | Fair Value, Measurements, Recurring
Cost or Amortized Cost
Cash and cash equivalents, at carrying value	46,245	59,144
Estimated Fair Value
Cash equivalents	46,245	59,144
Cash, cash equivalents, and restricted cash:
Total cash, cash equivalents, and restricted cash	46,245	59,144
Money markets funds | Fair Value, Measurements, Recurring
Cost or Amortized Cost
Cash and cash equivalents, at carrying value	137,293	65,599
Estimated Fair Value
Cash equivalents	137,293	65,599
Cash, cash equivalents, and restricted cash:
Total cash, cash equivalents, and restricted cash	$ 137,293	$ 65,599